C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 229/06 (2006.01) A61K 9/08 (2006.01) A61K 31/195 (2006.01) A61K 31/198 (2006.01)
Patent
CA 2319255
The use of N,N'-bis(2- hydroxybenzyl) ethylenediamine-N, N'-diacetic acid (HBED) in iron chelating therapy is disclosed. In particular, the invention relates to the subcutaneous use of HBED for treating mammals with a disease treatable by an iron chelator such as iron overload, especially transfusional iron overload.
L'invention concerne l'utilisation de l'acide N,N'-bis(2- hydroxybenzyl) éthylènediamine-N, N'-diacétique (HBED) dans le traitement par chélation du fer. Elle concerne en particulier l'utilisation sous-cutanée de l'HBED pour traiter les mammifères atteints d'une maladie pouvant être traitée par un chélateur du fer, telle qu'une surcharge en fer, notamment une surcharge en fer post-transfusionnelle.
Fetherstonhaugh & Co.
University Of Florida Research Foundation Inc.
LandOfFree
Pharmaceuticals comprising n,n'-bis(2- hydroxybenzyl)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceuticals comprising n,n'-bis(2- hydroxybenzyl)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceuticals comprising n,n'-bis(2- hydroxybenzyl)... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1961619